Thyroid gland and pregnancy – summary of important findings

Czech version

Authors: Zdeňka Límanová
Authors‘ workplace: III. interní klinika 1. LF UK a VFN Praha, přednosta prof. MUDr. Štěpán Svačina, DrSc., MBA
Published in: Vnitř Lék 2015; 61(10): 862-687
Category: Reviews

Overview

Thyroid hormones play fundamental role in conception and pregnancy and are essential for normal adult health, fetus and childhood development. Many studies have shown an association between maternal thyroid diseases esp. hypothyroidism with obstetric problems and/or psychomotoric impairment in the offspring. The prevalence of undiagnosed lower thyroid function in pregnancy is present in about 4–8 % of pregnant women, and euthyroid women with thyroid autoimmunity (6–8 %) are further candidates for thyroid disorders in pregnancy. The thyroid gland needs to produce 50 % more thyroxine in pregnancy to maintain an euthyroid state to keep TSH ideally ≤ 2.5 mIU/l in the first trimester of pregnancy and TSH ≤ 3.0 mIU/l in the second and third trimester. Consequently, there is a need to start the substitution therapy as soon as diagnosis of subclinical and /or overt hypotyroidism is established, and in majority of euthyroid women with autoimmune thyroid disease there is a need to start therapy as well. Most women on levothyroxine therapy before pregnancy require an increase in dose when pregnant. As maternal thyroid disease is a quite prevalent condition and often asymptomatic, but easily diagnosed and for which an effective, safe and cheap treatment is available, endocrinological societies including ČES ČLS JEP worldwide are suggesting the need of thyroid dysfunction screening as a simple prevention attitude. Hormone determination of TSH and TPOab antibodies should be performed early during the first trimester, using trimester-specific reference values. Furthermore, adequate iodine supplementation during pregnancy is critical and if feasible it should be initiated before the woman attempts to conceive.

Key words:
anti TPOab – pregnancy – screening of thyroid dysfunction – thyroid – TSH

Sources

1. Zamrazil V, Čeřovská J. Jod a štítná žláza. Optimální přívod jodu a poruchy z jeho nedostatku. Mladá fronta: Praha 2014. ISBN 978–80–204–3302–2.

2. Zamrazil V. Saturace jodem v České republice a ve světě – nedostatky a perspektivy. Kardiologická revue 2015; 17(2): 167–171.

3. Farebrother J, Naude CE, Nicol L et al. Systematic review of the effect of iodised salt and iodine supplements and postanatal growth: study protocol. BMJ Open 2015; 5(4): e007238. Dostupné

4. z DOI: <http://dx.doi.org/10.1136/bmjopen-2014–007238>.

5. Chan S., Kilby MD. Thyroid hormone and central nervous system development. J Endocrinol 2000; 165(1): 1–5.

6. Zoelller RT, Rover J. Timing of thyroid hormone action in developing brain: clinical observation and experimental findings. J Neuroendocrinol 2004; 16(10): 809–818.

7. Morreale de Escobar G, Obregon MJ, Escobar del Rey F et al. Role of thyroid hormone during early brain development. Eur J Endocrinol 2004; 151(Suppl 3): U25-U37.

8. Neumann D, Krylová K, Al Taji E et al. Klinické souvislosti vývoje štítné žlázy a jejich poruch u plodu a novorozence (2. část). Čes Slov Pediat 2013; 68(5): 331–341.

9. Flamant F, Koibuchi N, Bernal J. Thyroid hormone in brain and brain cells. Front Endocrinol (Lausanne) 2015; 6: 99. Dostupné z DOI: <http://dx.doi.org/10.3389/fendo.2015.00099>.

10. Jiskra J, Fait T, Bílek R et al. Mild iodine deficiency in women after spontaneous abortion living in iodine-suffitient area of Czech republic: prevalence and impact on reproductive health. Clin Endocrinol (Oxf) 2014; 80(3): 452–458.

11. Kvíčala J, Jiránek V, Nĕmecek J et al. Selenium deficiency of west Bohemia population. Vnitř Lék 2006; 52(10): 873–880.

12. Thangaratinam S, Tan A, Knox E et al. Assotiation between thyroid autoantibodies and miscarrriage and preterm birtsh: metaanalysis of evidence. BMJ 2011; 342: d2616. Dostupné

13. z DOI: <http://dx.doi.org/10.1136/bmj.d2616>.

14. Haddow EJ, Glenn E, Palomaki F et al. Maternal thyroid deficiency during pregnancy and subsequent neuropsychological development on the child. N Engl J Med 1999; 341(8): 549–555.

15. Springer D, Horáček J, Hauerová D et al. Thyroid malfunction in pregnancy. Čes Gynek 2007; 72(6): 375–381.

16. Límanová Z, Springer D. Thyreopathy examination during pregnancy-results of pilot project. Čas Lék Čes 2011; 150(7): 389–393.

17. Skřivánek A, Lubušký M, Studnička M et al. Epidemiologie a management poruch štítné žlázy v těhotenství. Čes Gyn 2013; 78(1): 62–67.

18. Sarapatkova H, Sarapatka J, Frysak Z. What is the benefit of screening for thyroid function in pregnant women in the detection of newly diagnosed thyropathies? Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub 2013; 157(4): 358–362.

19. Horáček J, Jiskra J, Límanová Z et al. Doporučení pro diagnostiku a léčbu onemocnění štítné žlázy v těhotenství a pro ženy s poruchou fertility. Vnitř Lék 2013; 59(10): 909- 931.

20. Stagnaro-Green A, Abalovich M, Alexander E et al. Guidelines of the American Thyroid Association for the diagnosis and management of thyroid disease during pregnancy and postpartum. Thyroid 2011; 21(10): 1081–1125.

21. Vaidya B, Anthony S, Bilous M et al. Detection of thyroid dysfunction in early pregnancy: universal screening or targeted high-risk case finding? J Clin Endocrinol Metab 2007; 92(1): 203–207.

22. Horacek J, Spitalnikova S, Dlabalova B et al. Universal screening detects two-times more thyroid disorders in early pregnancy than targeted high-risk case finding. Eur J Endocrinol 2010; 163(4): 645–650.

23. Kwak-Kim J, Han AR, Gilman-Sachs A et al. Current trends of reproductive immunology practices in in vitro fertilization (IVF) – a first world survey using IVF-Worldwide.com. Am J Reprod Immunol 2013; 69(1): 12–20.

24. Bartáková J, Potluková E, Rogalewitz V et al. Screening for autoimmune thyroid disorders after spontaneous abortion is cost-saving and it improves the subsequent pregnancy rate. BMC Pregnancy Childbirth 2013; 13: 217. Dostupné z DOI: <http://dx.doi.org/10.1186/1471–2393–13–217>.

25. Mannisto TM, Vaarasmaki A, Pouta AL et al. Thyroid dysfunction and autoantibodies during pregnancy as predictive factors of pregnancy complications and maternal morbidity in later life. J Clin Endocrinol Metab 2010; 95(3): 1084–1094.

26. Toulis KA, Goulis DG, Venetis C et al. Risk of spontaneous miscarriage in euthyroid women with thyroid autoimmunity undergoing IVF: a meta-analysis. Eur J Endocrinol 2010; 162(4): 643–652.

27. Springer D, Bartoš J, Zima T. Reference intervals for thyroid markers in early pregnancy determined by 7 different analytical systems. Scand J Lab Invest 2014; 74(2): 95–101.

28. Balucan FS, Morsheas SA, Davies TF. Thyroid autoantibodies in pregnancy: their role, regulation and clinical relevance. J Thyroid Res 2013; 182472. Dostupné z DOI: <http://dx.doi.org/10.1155/2013/182472>.

29. Chang DL, Leung AM, Braverman LE et al. Thyroid testing during pregnancy at an academic Boston area Medical center. J Clin Endocrinol Metab 2011; 96(9): e1452-e1456. Dostupné z DOI: <http://dx.doi.org/10.1210/jc.2011–0360>.

30. Vaidya B, Hubalewska-Dydejczyk A, Laurberg P et al. Treatment and screening of hypothyroidism in pregnancy: results of a European survey Eur J Endocrinol. 2012; 166(1): 49–54.

31. Granfors M, Åkerud H, Berglund A et al. Thyroid testing and management of hypothyroidism during pregnancy: a population-based study. J Clin Endocrinol Metab 2013; 98(7): 2687–2692.

32. Pop V, Broeren M, Wiersinga W. The attitude toward hypotyhroidism during early gestation: time for a change of mind? Thyroid 2014; 24(10): 1541–1546.

33. Gronowski AM, Haddow J, Lazarus JH et al. Thyroid function during pregnancy: Who and how shlould we screen? Clinical Chemistry 2012; 58(10): 1397–1401.

34. De Groot L, Abalovich M, Alexander EK et al. Management of thyroid dysfunction during pregnancy and postpartum: an Endocrine Society clinical practice guideline. J Clin Endocrinol Metab 2012; 97(8): 2543–2565.

35. 33 Vila L, Velasco I, González S et al. Controversies in endocrinology: On the need for universal thyroid screening in pregnant women. Eur J Endocrinol. 2013; 170(1): R17-R30.

36. Taylor PN, Okosieme OE, Premawardhana L et al. Should all women be screened for thyroid dysfunction in pregnancy? Womens Health 2015; 11(3): 295–307.

37. Thung SF, Funai EF, Grobman WA. The cost effectiveness of universal screening in pregnancy for subclinical hypothyroidism. Am J Obstet Gynecol 2009; 200(3): 267.e1–267.e7. Dostupné z DOI: <http://dx.doi.org/10.1016/j.ajog.2008.10.035>.

38. Dosiou CH, Barnes J, Schwartz A et al. Cost-Effectivnss of Universal and Risk-Based Screening for Autoimmune Thyroid Disease in Pregnant Women. J Clin Endocrinol Metab 2012; 97(5): 1536–1546.

39. Bartáková J, Potluková E, Rogalewitz V et al. Screening for autoimmune thyroid disorders after spontaneus abortion is cost-saving and it improves the subsequent pregnancy rate. BMC Pregnancy Childbirth 2013; 13: 217. Dostupné z DOI: <http://dx.doi.org/10.1186/1471–2393–13–217>.

40. Springer D, Potlukova E, Limanova Z et al. Recommendations on prenatal screening and the connections to other diseases such as thyroid dysfunction. Clin Chem Lab Med 2012; 50(7): 1211–1220.

41. Jiskra J, Límanová Z. Screening tyreopatií v těhotenství. Prak Gyn 2013; 17(1): 61–68.